Table A3.
Analysis | Treatment | Univariable HR (95% CI) | Multivariable HR (95% CI)* |
---|---|---|---|
Overall, uncensored | Chemotherapy alone | 1.29 (1.14 to 1.47) | 1.37 (1.20 to 1.58) |
Preoperative chemotherapy | 0.78 (0.67 to 0.92) | 0.94 (0.78 to 1.13) | |
Overall, censored for adjuvant chemotherapy | Chemotherapy alone | 1.10 (0.95 to 1.26) | 1.19 (1.01 to 1.40) |
Preoperative chemotherapy | 0.66 (0.55 to 0.79) | 0.81 (0.66 to 1.00) | |
Overall, censored for adjuvant chemotherapy, adjusted for pathologic stage and surgical margin status | Preoperative chemotherapy | 0.84 (0.69 to 1.03) | 1.01 (0.81 to 1.27) |
Cystectomy only, adjusted for pathologic stage and surgical margin status | Adjuvant chemotherapy | 0.65 (0.54 to 0.78) | 0.71 (0.58 to 0.87) |
Abbreviation: HR, hazard ratio.
Multivariable models included age, gender, race, insurance status, median income, education, Charlson Comorbidity Index, year of diagnosis, facility type, facility location, facility setting, distance to facility, annual cystectomy volume, clinical T stage, and clinical N stage.